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OBJECTIVES This study was designed to assess the incremental prognostic value of adenosine stress
myocardial perfusion single-photon emission computed tomography (MPS) in women versus
men, and to explore the prognostic impact of diabetes mellitus.
BACKGROUND Limited data are available regarding the incremental value of adenosine stress MPS for the
prediction of cardiac death in women versus men and the impact of diabetes mellitus on
post-adenosine MPS outcomes.
METHODS Of 6,173 consecutive patients who underwent rest thallium-201/adenosine technetium-99m
sestamibi MPS, 254 (4.1%) were lost to follow-up, and 586 with early revascularization 60
days after MPS were censored, leaving 2,656 women and 2,677 men.
RESULTS Women had significantly smaller adenosine stress, rest, and reversible defects than men.
During 27.0  8.8 month follow-up, cardiac death rates were lower in women than men
(2.0%/year vs. 2.7%/year, respectively, p  0.05). Before and after risk adjustment, cardiac
death risk increased significantly in both men and women as a function of MPS results.
Multivariable models revealed that MPS results provided incremental prognostic value over
pre-scan data for the prediction of cardiac death in both genders. Also, while comparative
unadjusted rates of early (60 days post-test) coronary angiography (17% vs. 23%) and
revascularization (8% vs. 12%) were significantly lower in women (p  0.05), after adjusting
for MPS, these rates were similar in men and women. Importantly, diabetic women had a
significantly greater risk of cardiac death compared with other patients. Also, after risk
adjustment, patients with insulin-dependent diabetes mellitus (IDDM) had higher risk of
cardiac death for any MPS result than patients with non–insulin-dependent diabetes mellitus.
CONCLUSIONS The findings suggest that adenosine MPS has comparable incremental value for prediction of
cardiac death in women and men and that MPS is appropriately influencing subsequent
invasive management decisions in both genders. Diabetic women and patients with IDDM
appear to have greater risk of cardiac death than other patients for any MPS result. (J Am
Coll Cardiol 2003;41:1125–33) © 2003 by the American College of Cardiology Foundation
Although there is evidence that women with coronary artery
disease (CAD) have a worse prognosis than men (1), it is
unclear whether women are treated similarly to men for any
given CAD amount (2–6). While stress myocardial perfu-
sion single-photon emission computed tomography (MPS)
is widely recognized as being useful for risk stratification in
CAD (7), only a few studies have compared the prognostic
value of MPS in men and women (6,8–10). Exercise MPS
has been found to provide incremental prognostic value over
clinical and exercise variables in both men and women.
Although a gender bias has been reported in which women
are less frequently catheterized than men (11,12), we pre-
viously reported that, with exercise MPS, apparent gender
differences in outcome disappeared, or were minimized,
after risk-adjusted analysis accounted for extent and severity
of perfusion abnormalities (6). Recently, adenosine MPS
has become the most common stress test in both men and
women who are unable to exercise or have nondiagnostic
stress electrocardiograms (ECGs). Yet, no study has inves-
tigated whether adenosine MPS provides comparable prog-
nostic information or has a comparable effect on invasive
management decisions in women and men. Additionally,
while diabetes mellitus (DM) has been shown to be asso-
ciated with increased risk for any degree of MPS abnormal-
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ity in both genders (13) and to have a greater prognostic
impact in women (14), little is known about the relationship
between DM and the prognostic implications of adenosine
MPS in women compared with men. Thus, the present
study sought to define whether adenosine MPS in women
versus men provides similar incremental prognostic value or
has comparable risk for any degree of perfusion abnormality,
and to explore the relationship of diabetes and outcome as a
function of adenosine MPS in both genders.
METHODS
Patients. The study population consisted of 6,173 consec-
utive patients with suspected or known CAD who had rest
thallium (Tl)-201/adenosine technetium (Tc)-99m sesta-
mibi dual-isotope MPS between 1991 and 1998 (each
patient only considered once). Patients with known valvular
heart disease or nonischemic cardiomyopathy were ex-
cluded. Of the initial population, 254 (4.1%) patients were
lost to follow-up leaving 5,919 patients. For the purpose of
prognostic assessment, 586 (9.9%) patients with early revas-
cularization (coronary artery bypass grafting [CABG] or
percutaneous coronary intervention [PCI] 60 days after
index MPS) were censored as previously described (15). The
final population consisted of 5,333 patients (2,656 women
and 2,677 men).
Rest Tl imaging. Patients were requested to be free of
the effects of nitrates, calcium blockers, and beta-blockers at
the time of MPS. Thallium-201 (3.0 to 4.5 mCi) was
injected intravenously at rest, and MPS acquisition was
started 10 min later (16). Patients with resting defects
usually returned for 24-h Tl-201 MPS to assess reversibility
(17).
Adenosine MPS protocol. Adenosine MPS was per-
formed as previously described (18). All patients were
instructed not to consume caffeine-containing products for
24 h before testing. Adenosine was infused at 140 g/kg/
min for 5 to 6 min. At the end of the second or third minute
of infusion (of the 5- and 6-min protocols, respectively),
Tc-99m sestamibi (25 to 40 mCi) was injected, and MPS
acquisition was started approximately 60 min later. During
adenosine infusion, 1,138 of 5,919 patients (44% women)
performed low-level treadmill exercise, walking at 0% to
10% grade and 1 to 1.7 mph.
MPS acquisition protocol. The MPS acquisitions were
performed as previously described with a circular or elliptical
180° acquisition for 64 projections at 25 s/projection for
Tc-99m or 35 s/projection for Tl-201 (16). All images were
subject to quality-control measures. No attenuation or
scatter correction was used. After filtered back projection,
short-axis, vertical long-axis, and horizontal long-axis to-
mograms were generated.
Stress ECG. During adenosine infusion, 12-lead ECG
was recorded each minute, with continuous monitoring of
aVF, V1, and V5. Significant ST-segment depression during
the adenosine stress test was defined as 1 mm of horizon-
tal or downsloping or 1.5 mm of upsloping (slope of
0.25 mV per 0.04 s) occurring 80 ms after the J point.
Image interpretation. Semiquantitative visual interpreta-
tion of MPS images used short-axis and vertical long-axis
tomograms divided into 20 segments for each patient (16).
Each segment was scored by consensus of two expert
observers using a five-point scoring system (0  normal,
4  absence of segmental uptake). Three global perfusion
indexes previously defined by our group were employed to
combine assessments of defect extent and severity (6). By
adding the 20 segment scores, summed stress scores (SSS)
and summed rest scores (SRS) were calculated, using the
24-h Tl-201 for SRS when available. The sum of the
differences between the SSS and SRS was defined as the
summed difference score (SDS), assessing defect reversibil-
ity. The SSS 4 was defined as a normal scan; SSS 4 to 8,
9 to 13, and 13 were defined as mildly, moderately, and
severely abnormal scans, respectively (19). The SDS2 was
considered no ischemia, 2 to 7 mild to moderate, and 7
severe ischemia (20). The SRS 2 was considered normal,
2 to 7 mild to moderate, and 7 extensive resting defects.
Follow-up data. Follow-up was performed at 27.0  8.8
months (all1 year) by trained research personnel. The sole
end point examined was cardiac death, confirmed by death
certificate or medical records. Early revascularization was
defined as performance of PCI or CABG 60 days after
MPS.
Statistical analysis. All continuous variables are expressed
as mean  1 standard deviation. Univariate analyses of
continuous variables used unpaired t test. Univariate analy-
ses of categorical variables were compared by chi-square. A
threshold 0.05 was considered significant. The pre-scan
likelihood of CAD was calculated by CADENZA (Ad-
vanced Heuristics Inc., Bainbridge Island, Washington)
(21), which was based on clinical and historic information.
For patients with known CAD, this likelihood is considered
to represent the likelihood of ischemia.
The Kaplan-Meier method was used to depict survival
curves. Cox proportional hazards model (S-PLUS 2000,
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
CAD  coronary artery disease
DM  diabetes mellitus
ECG  electrocardiogram
IDDM  insulin-dependent diabetes mellitus
MI  myocardial infarction
MPS  myocardial perfusion single-photon emission
computed tomography
NIDDM  non–insulin-dependent diabetes mellitus
PCI  percutaneous coronary intervention
ROC  receiver operating characteristic
SDS  summed difference score
SRS  summed rest score
SSS  summed stress score
Tc  technetium
Tl  thallium
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MathSoft, Inc., Seattle, Washington) identified univariable
and multivariable predictors of cardiac events. Selection of
variables for consideration for entry was based on both
univariate statistical significance and clinical judgment. A
stepwise multivariable Cox regression analysis was per-
formed using: 1) pre-MPS data (clinical and historical
information), and 2) the increment in prognostic value after
“forcing in” the significant clinical variables and then adding
the most predictive nuclear variable(s). A significant in-
crease in the global chi-square of a model after addition of
the nuclear variables indicated incremental prognostic value.
Based upon these models, we derived risk-adjusted cumu-
lative survival curves to compare women and men with
normal and varying degrees of abnormal MPS. These
models were performed in the overall cohort as well as in
men and women separately.
Receiver operating characteristic (ROC) curve analysis
was performed to compare the value of combined clinical
and MPS results for predicting cardiac events in men versus
women using the final Cox model. The differences between
ROC curve areas (area  SE) were compared (22).
RESULTS
Patient characteristics. Clinical characteristics by gender
are shown in Table 1. Men and women differed with respect
to all clinical characteristics except diabetes. The women
were older, had higher pre-scan likelihood of CAD, more
frequently had hypertension, hypercholesterolemia, anginal
symptoms, and ischemic stress ECG; however, women less
frequently had prior myocardial infarction (MI), PCI,
CABG, shortness of breath, abnormal rest ECG, smoked,
and underwent low-level treadmill exercise during adeno-
sine stress compared with men (p  0.02).
Adenosine MPS results. The MPS findings are shown in
Table 2. Compared with men in the respective group,
women had significantly lower SSS, SRS, and SDS, and a
lower frequency of abnormalities of each of the subcatego-
ries of these perfusion findings.
Outcome events. During follow-up 117 cardiac deaths
(4.4%) occurred in women and 164 (6.1%) in men (p 
0.01). Annual rates of cardiac death rose significantly as a
function of SSS and are illustrated in Figure 1. Although
the overall rates of cardiac death were lower in women than
in men, after stratification by SSS, cardiac death rates in
women and men were similar across scan categories (p 
NS). This apparent discrepancy is explained by the greater
frequency of normal scans in women than in men. Two-year
unadjusted Kaplan-Meier survival estimates are shown in
Figure 2 for men and women as a function of SSS. In both
men and women, a significant decrease in survival is present
with increasing SSS, with worsened observed survival in
women compared with men (men vs. women, p  NS).
Women tended to have worse survival in the setting of more
severe and extensive perfusion defects, although this differ-
ence did not reach statistical significance (Figs. 1 and 2).
Table 1. Patient Characteristics
Women
(n  2,656)
Men
(n  2,677)
Age 72  11* 70  11
Prior MI 561 (21%)* 933 (35%)
History of PCI 288 (11%)* 500 (19%)
History of CABG 266 (10%)* 755 (28%)
Hypertension 1,669 (63%)* 1,406 (53%)
Diabetes 608 (23%) 614 (23%)
Hypercholesterolemia 1,219 (46%)* 1,070 (40%)
Smoking 263 (10%)* 385 (14%)
Angina 1,407 (53%)* 1,146 (43%)
Shortness of breath 252 (9%)* 283 (11%)
Abnormal rest ECG 1,685 (63%)* 1,907 (71%)
Ischemic stress ECG 205 (8%)* 124 (5%)
Pre-scan Lk of CAD/ischemia 47  30%* 43  33%
With low-level exercise 447 (17%)* 538 (20%)
*p  0.02 vs. men.
CABG  coronary artery bypass grafting; CAD  coronary artery disease;
ECG  electrocardiogram; Lk of CAD/ischemia  likelihood of CAD (in the
suspected CAD patients) or ischemia (in the CAD patients); MI  myocardial
infarction; PCI  percutaneous coronary intervention.
Table 2. Adenosine MPS Variables in Women and Men
Women
(n  2,656)
Men
(n  2,677)
SSS 4.8  7.5* 9.7  10.4
Normal (0–3) 1,649 (62%)* 1,004 (38%)
Mild abnormal (4–8) 476 (18%) 542 (20%)
Moderate abnormal (9–13) 199 (8%)* 325 (12%)
Severe abnormal (13) 332 (13%)* 806 (30%)
SDS 3.1  5.2* 5.1  6.5
No ischemia (0–1) 1,551 (58%)* 1,126 (42%)
Mild-moderate ischemia (2–7) 697 (26%)* 808 (30%)
Severe ischemia (7) 408 (15%)* 743 (28%)
SRS 1.6  4.7* 4.4  8.1
No defect (0–1) 2,156 (81%)* 1,635 (61%)
Mild-moderate defect (2–7) 293 (11%)* 499 (19%)
Extensive defect (7) 207 (8%)* 543 (20%)
*p  0.002 vs. men.
MPS  myocardial perfusion single phiton emission computed tomography;
SDS  summed difference score; SRS  summed rest score; SSS  summed stress
score.
Figure 1. Annual rates of cardiac death in women (open bars) and men
(solid bars) as a function of myocardial perfusion single-photon emission
computed tomography results. *p  0.001 across scan categories. abnl 
abnormal; Mod  moderate; Sev  severe.
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Early catheterization and revascularization. In the un-
censored groups of 2,878 women and 3,041 men, overall
referral rates to catheterization and revascularization within
60 days after MPS were lower in women than men (Table
3). However, after adjusting for the extent and severity of
inducible ischemia or scan abnormality, no gender-related
differences remained. Of interest, only 3% of women and
men underwent early catheterization when SSS was 4,
and those catheterized rarely underwent early revasculariza-
tion. Patients with SSS 2 to 3 had low rates of early
catheterization and revascularization, which were higher
than in patients with SSS 0 to 1 (all, p  0.05), but with no
gender differences. In both genders, increases in referral
rates as a function of worsening ischemia were noted (p 
0.001).
Multivariable survival analysis. The significant vari-
ables predictive of cardiac death by Cox models in the
overall cohort, women, and men are shown in Table 4
(chi-square  399, 202, and 199, respectively; all, p 
0.0001). In all three models, SSS and age were nonlinear
and, thus, quadratic terms were added to the Cox model to
satisfy its linearity assumptions (SSS2, age2). Further, a
significant interaction was present between patient gender
and diabetes, such that a greater risk of cardiac death was
predicted for female diabetics over female nondiabetics or
male diabetics. After adjustment for pre-MPS variables,
addition of SSS provided a significant increase in chi-square
(42% gain in chi-square), indicative of incremental prog-
nostic value (Fig. 3) (p  0.0001). In both men (gain in
chi-square  93) and women (gain in chi-square 40), the
addition of SSS yielded incremental information over pre-
scan data alone for prediction of cardiac death (both, p 
0.0001).
Predicted mortality rates based on the overall model are
Figure 2. Unadjusted two-year Kaplan-Meier survival estimates in men and women as a function of summed stress score. No significant difference is
present.
Table 3. Unadjusted Rates of Referral to Early Coronary Catheterization and Revascularization as a Function of Inducible Ischemia
in Women and Men
Catheterization Revascularization
Women Men Women Men
Total 17% (492/2,878)* 23% (705/3,041) 8% (222/2,878)* 12% (364/3,041)
Normal 3% (53/1,661) 3% (30/1,010) 0.7% (12/1,661) 0.6% (6/1,010)
SSS 0–1 2% (32/1,374) 2% (16/820) 0.5% (7/1,374) 0.1% (1/820)
SSS 2–3 7% (21/287)† 7% (14/190)† 2% (5/287)‡ 3% (5/190)†
Abnormal 36% (439/1,217) 33% (675/2,031) 17% (210/1,217) 18% (358/2,031)
No ischemia 14% (20/139) 13% (36/278) 4% (5/139) 4% (10/278)
Mild-moderate ischemia 26% (134/521) 22% (159/735) 11% (56/521) 10% (73/735)
Severe ischemia 51% (285/557)§ 47% (480/1,018)§ 27% (149/557)§ 27% (275/1,018)§
*p  0.001 vs. men; †p  0.0001 vs. SSS 0–1; ‡p  0.05 vs. SSS 0–1; §p  0.001 among groups.
SSS  summed stress score.
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shown separately for nondiabetic men and women versus
diabetic men and women (Figs. 4A and 4B). Among
nondiabetics, predicted survival was nearly identical in men
and women. However, among diabetics, women had a
significantly higher predicted rate of cardiac death com-
pared with men based on the Cox proportional hazards
model.
The presence of prior CAD was of prognostic signifi-
cance even after adjusting for other factors, but its value
varied both as a function subset of prior CAD and patients
examined. In the overall cohort, prior CABG was an
incremental predictor of cardiac death in the overall cohort.
In men, both prior CABG and prior PCI were predictive of
cardiac death, while, in women, MI, but not revasculariza-
tion, was an incremental predictor.
Comparison of prognostic value in women and men.
The ROC curves showed excellent discrimination for pre-
dicting cardiac events in women and men using SSS (after
adjusting for clinical variables). No gender-related differ-
ences in ROC areas were present (0.78  0.02 vs. 0.83 
0.02, p  NS). These findings demonstrate that adenosine
MPS is equally effective in identifying both men and women
at high risk of cardiac mortality.
Comparison of insulin-dependent diabetes mellitus
(IDDM) versus non–insulin-dependent diabetes melli-
tus (NIDDM). Subgroup analysis was performed in 2,826
patients from the overall cohort in whom information was
available regarding the presence of IDDM or NIDDM.
The characteristics of nondiabetics and two types of diabet-
ics are shown in Table 5. The IDDM group was younger,
more frequently had prior MI, PCI and CABG, hyperten-
sion, shortness of breath, and greater stress, rest, and
reversible defects on MPS among the three groups (p 
0.05). However, they less frequently had angina, ischemic
stress ECG, and had lower pre-scan likelihood of CAD (p
Table 4. Multivariable Predictors of Cardiac Death in the
Overall Population, Women and Men
Model Overall Women Men
Age*   
Male gender   
History of MI   
History of CABG   
History of revascularization   
Digoxin use   
Diabetes   
Cholesterol 1   
Shortness of breath   
Abnormal rest ECG   
Left bundle branch block   
Adenosine stress with walking   
SSS*   
Total chi-square 399 202 199
p Value  0.00001  0.0001  0.0001
*Modelled nonlinearly in all three models.   significant in model;   not
significant in model.
Abbreviations as in Tables 1 and 2.
Figure 3. Chi-square values from the Cox proportional hazards models for
the overall cohort, women, and men. Increase in chi-square is significant in
all (*p  0.0001). Solid bar  pre-MPS; open bar  pre-MPS  SSS.
Figure 4. (A) Predicted cardiac mortality based on Cox proportional
hazards model in nondiabetic men and women with normal, mildly,
moderately, and severely abnormal scans. Significant difference in mortality
as a function of increasing summed stress score (SSS) as based on the
multivariable model (p 0.0001). (B) Predicted cardiac mortality based on
Cox proportional hazards model in diabetic men and women with normal,
mildly, moderately, and severely abnormal scans. Significant difference in
mortality as a function of increasing SSS as based on the multivariable
model (p  0.0001). abnl  abnormal; Mod  moderate; Sev  severe.
Solid bar  men; open bar  women.
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 0.05). There was no difference in use of low-level exercise
during adenosine stress (p  NS).
Observed cardiac mortality in these subgroups is shown
in Figure 5. A significant difference in cardiac mortality was
present between patients with IDDM, NIDDM, and non-
diabetics in the setting of both normal and abnormal scans
(both, p  0.05). Further, a significant difference between
normal and abnormal scans was present in nondiabetics as
well as in patients with IDDM (p 0.05). There was a very
high rate of cardiac death in patients with IDDM and
abnormal scans. Cox proportional hazards modeling of this
subgroup using the same variables as the overall model
revealed a greater cardiac death risk with IDDM than
NIDDM patients, and nondiabetics having the lowest risk
(Fig. 6) (p  0.001).
DISCUSSION
The present study demonstrates that adenosine Tc-99m
sestamibi MPS provides significant incremental prog-
nostic information over historical and clinical data in
both women and men. Although women had smaller
overall stress, rest, and reversible defects and lower overall
cardiac mortality compared with men, they were at similar
risk for adverse events as a function of adenosine MPS
results according to both unadjusted and adjusted data.
Multivariable modeling revealed that a significant inter-
action was present between gender and DM such that,
although men and women without diabetes have similar
risk, women with DM are at greater risk than either men
with DM or women without DM. The ROC curve anal-
ysis showed no significant differences between the overall
cohort of women and men for predicting cardiac death
using MPS. Regarding impact on patient management of
adenosine MPS, referral rates to early catheterization
and revascularization paralleled the level of risk by MPS in
both women and men. Overall, women had lower referral
rates compared with men because of a large proportion of
women with normal scans. An interesting finding emerging
from assessment of the overall cohort was that, for any
degree of SSS abnormality on adenosine MPS, patients
with diabetes have a higher event rate than nondiabetics
after risk adjustment for confounding variables. Subgroup
analyses revealed that IDDM patients had an even higher
risk compared with NIDDM patients, whose risk was
higher than that of nondiabetic controls. Even in patients
with normal scans, the presence of IDDM was associated
Table 5. Clinical and Adenosine MPS Data by Diabetic Status
Nondiabetics
(n  2,237)
NIDDM
(n  354)
IDDM
(n  235)
Age 72  11 71  10 66  12*
Female gender 1,108 (50%) 167 (47%) 125 (53%)
Prior MI 550 (25%) 102 (29%) 84 (36%)*
History of PCI 335 (15%) 54 (15%) 62 (26%)*
History of CABG 386 (17%) 86 (24%) 61 (26%)*
Hypertension 1,239 (55%) 238 (67%) 174 (74%)*
Hypercholesterolemia 1,000 (45%) 188 (53%)* 120 (51%)
Smoking 224 (10%) 29 (8%) 25 (11%)
Angina 1,162 (52%) 185 (52%) 106 (45%)*
Shortness of breath 241 (11%) 56 (16%) 41 (17%)*
Abnormal rest ECG 1,447 (65%) 234 (66%) 180 (77%)*
Ischemic stress ECG 176 (8%) 38 (11%) 10 (4%)*
Pre-scan Lk of CAD/ischemia 44  31% 53  32% 42  35%*
With low-level exercise 794 (35%) 118 (33%) 71 (30%)
SSS 5.4  8.3 7.7  9.5 9.5  10.6*
SRS 2.4  6.3 3.2  7.0 3.9  7.5*
SDS 2.9  5.0 4.4  6.3 5.4  7.0*
*p  0.05 among groups.
IDDM  insulin-dependent diabetes mellitus; NIDDM  non–insulin-dependent diabetes mellitus. Other abbreviations as
in Tables 1 and 2.
Figure 5. Cardiac mortality in patients without diabetes mellitus (DM)
(solid bar), with non–insulin-dependent diabetes mellitus (NIDDM)
(open bar), and with insulin-dependent diabetes mellitus (IDDM)
(hatched bar) after normal versus abnormal myocardial perfusion single-
photon emission computed tomography (MPS). *p  0.05 among non–
DM, NIDDM, and IDDM within MPS categories; †p  0.05 between
normal and abnormal MPS.
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with a tendency to greater risk than NIDDM and non-
diabetics.
Comparison with previous vasodilator MPS studies.
While several studies have evaluated the incremental prog-
nostic value of exercise MPS in women (6,8–10,23), only a
few considered the prognostic implications of vasodilator
stress MPS. Amanullah et al. (24) have shown that adeno-
sine stress MPS added significant incremental prognostic
value to clinical variables in women; however, there were no
comparable data regarding men. In another study by Travin
et al. (9), men and women with abnormal dipyridamole
Tc-99m sestamibi MPS had similar event rates.
Our group previously reported the incremental value, role
in risk stratification and post-MPS resource utilization of
stress adenosine studies in a more limited cohort of 1,159
patients (25). We described that risk stratification was
achieved by this test in men and women, and demonstrated
the incremental prognostic value of this test in the overall
cohort. Due to the limited size of the cohort, the detailed
comparison of men and women contained in the present
manuscript was not performed. Further, the impact of DM
on the prognostic relationships was not addressed.
Comparison with previous exercise MPS studies. To our
knowledge, this is the first study in a large population to
compare the prognostic significance of adenosine stress
MPS in women and men. Women less frequently had
abnormal scan results, and only 21% of women but 42% of
men had moderately to severely abnormal results on aden-
osine MPS. However, adenosine stress MPS provided
comparable prognostic value for women and men in each
category of perfusion defect abnormality. In the stepwise
multivariable model, a similar increase in chi-square was
seen in men and women by addition of adenosine MPS
results to clinical data.
These findings are similar to what has been reported with
exercise MPS; however, our findings revealed a greater
mortality risk after adenosine stress than previously reported
with exercise MPS in every category of scan abnormality.
Pancholy et al. (23) examined 212 women who underwent
coronary angiography and showed that exercise Tl201-MPS
had independent and incremental prognostic value. Subse-
quently, Hachamovitch et al. (8) reported that exercise
Tc-99m sestamibi MPS yielded incremental prognostic
value in both women and men. In this study from our
laboratory comprising 2,742 men and 1,934 women, we
demonstrated that exercise MPS identifies low-risk women
and men equally well, but relatively high-risk women more
accurately than relatively high-risk men. Exercise MPS,
therefore, was able to stratify women more effectively than
men (8).
It has been generally appreciated that patients who
undergo pharmacologic stress are “sicker” than patients who
undergo exercise testing. In 1998, Hachamovitch et al. (19)
reported that patients who underwent pharmacologic stress
were older, more frequently had previous cardiac events or
procedure, had a higher likelihood of CAD, more severe
and extensive scan abnormalities, and greater subsequent
rates of adverse outcomes. Others have found similar results
(26,27). The use of pharmacologic stress rather than exer-
cise has been shown to be an incremental predictor of poor
Figure 6. Relationship between log relative hazard for predicted cardiac mortality and summed stress score in insulin-dependent diabetes mellitus (IDDM),
non–insulin-dependent diabetes mellitus (NIDDM), and nondiabetics. p  0.001.
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prognosis over clinical, historical, and single-photon emis-
sion computed tomography data (19,20,27).
Relationship between adenosine MPS findings and re-
ferral to catheterization. Overall, a larger proportion of
men were referred to early catheterization and revascular-
ization than women in the current study. However, after
adjusting for the extent and severity of inducible ischemia or
scan abnormality, catheterization and revascularization rates
were similar in men and women. In 1995, Hachamovitch et
al. (6) reported on apparent gender-related differences in
clinical management in patients undergoing exercise sesta-
mibi MPS. Although men were referred to catheterization
more frequently than women early after nuclear testing,
there were no differences in the rate of referral to catheter-
ization or revascularization after stratification by the amount
of abnormally perfused myocardium as determined by the
SSS. In fact, in this previous study, women with extensive
inducible ischemia had greater referral rates to catheteriza-
tion than men. Despite generally similar referral rates to
catheterization, the cardiac event rates were observed to be
higher in women than in men. In the current study, despite
the greater overall risk and associated catheterization and
revascularization rates in men compared with women,
gender-related differences were not generally present with
respect to risk or resource utilization after adjusting for
confounding factors, such as the MPS results.
Impact of DM on cardiovascular risk in women under-
going MPS. The current study shows that diabetic women
have a significantly greater risk of cardiac death for any
degree of scan abnormality compared with diabetic men or
nondiabetic men or women. In studies not using MPS,
younger women have been shown to be at a much lower risk
of coronary disease mortality than men; however, multiple
studies have shown that diabetes “erases” this female advan-
tage, increasing the risk of heart disease much more in
women than in men. Barrett-Connor et al. (14), in a
14-year follow-up of 207 men and 127 women with
NIDDM compared with 2,137 adult controls, first showed
the excess risk associated with DM in women compared
with men. In their study, Cox proportional hazards model-
ing revealed the relative hazard of CAD in diabetics versus
nondiabetics, after adjusting for age, was 3.3 in women and
1.8 in men, and remained the same even after adjusting for
age, systolic blood pressure, cholesterol, body mass index,
and cigarette smoking. Further, a recent meta-analysis of 16
prospective cohort studies containing both men and women
with and without diabetes found that, after adjusting for
other cardiac risk factors, the relative risk of coronary death
from diabetes was 2.58 (95% confidence interval, 2.05 to
3.26) for women and 1.85 (1.47 to 2.33) for men (difference,
p  0.05) (28). Although the precise physiological mecha-
nisms for the greater risk of diabetic women compared with
men has not been elucidated, it is believed that they are at
least partially related to greater lipid abnormalities as well as
more insulin resistance resulting in premature, accelerated
vascular disease (29).
Regarding diabetes and MPS, in a cohort of 1,271
patients with and 5,862 patients without diabetes undergo-
ing either exercise or adenosine MPS, Kang et al. (13)
previously demonstrated that risk-adjusted event rates were
higher in patients with diabetes than in those without
diabetes in all SSS categories. These results were supported
by a subsequent multisite data registry reporting a smaller
group of diabetics (30). Our results are consistent with
previous studies examining the impact of DM on cardio-
vascular risk in women and extend them to the extrapolation
of risk in diabetic women from MPS results.
IDDM versus NIDDM. In the overall cohort, men and
women combined, we found that there was an increased risk
in the IDDM beyond that observed in NIDDM. After risk
adjustment we found that the increased risk extended across
the entire spectrum of MPS results. To our knowledge this
increased risk for any MPS finding in patients with IDDM
has not been previously reported.
Study limitations. This is a retrospective study in nature,
although all data were collected and entered prospectively.
The patients in this study were referred to a university-
affiliated community hospital in a major urban area limiting
the generalizability of the findings. Assessments of global
and regional ventricular function with gated MPS were not
performed in this study, as gated MPS was not routinely
performed in our laboratory until 1995.
In this study, patients were not formally tested for the
presence of DM. Hence, the “nondiabetic” group may have
contained undiagnosed diabetics that may have diluted the
study results. Although all patients were questioned regard-
ing the type of diabetes they had, insulin use was not
routinely recorded in the database until 1995.
Conclusions. The results of this study indicate that aden-
osine stress MPS has comparable strong incremental prog-
nostic value over clinical variables and has a similar effect on
catheterization and revascularization referrals in both men
and women. Women with DM are at greater risk of adverse
outcomes for any level of stress perfusion defects compared
with nondiabetic women or diabetic men. Patients with
IDDM have a greater risk than patients with NIDDM.
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